🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5 results for “Zhongshan” Clear

  1. Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles (hUCMSC-EVs)

    Shanghai Zhongshan Hospital

    Interstitial Lung Disease (ILD)

    phase 1 mab active

    1 trial

  2. 0.1% bromfenac

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Pterygium

    approved small molecule completed

    1 trial

  3. Tocilizumab

    Shanghai Zhongshan Hospital

    Takayasu Arteritis

    approved mab active

    1 trial

  4. Norepinephrine

    Shanghai Zhongshan Hospital

    Gastrointestinal Disease

    small molecule active

    1 trial

  5. Routine IOP-lowering medications

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Open Angle Glaucoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources